Luke Stavedahl, BS

Sharon Luu, MS, CGC

Early Diagnosis and Treatment by Newborn Screening (NBS) or Family History is Associated with Improved Visual Outcomes for Long-chain 3-hydroxyacylCoA Dehydrogenase Deficiency (LCHADD) Chorioretinopathy

  • Summarize the genetic origins, clinical features, and pathophysiology of LCHAD deficiency.
  • Examine the role of Newborn Screening in early identification of LCHAD deficiency and other inborn errors of metabolism.
  • Compare visual outcomes of LCHAD deficiency participants that were diagnosed via newborn screening to participants diagnosed symptomatically.
Session date: 
11/13/2024 - 4:00pm to 5:00pm CST
Location: 
Virtual
WI
United States
See map: Google Maps
  • 1.00 AAPA Category 1 CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 CDR CPEUs
  • 1.00 NSGC Category 1 CEU Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar: 

Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Luke Stavedahl, BS (grad student)
Sharon Luu, MS, CGC